U.S. News
Jen Rynda/The Baltimore Sun/Tribune News Service via Getty Images
FDA Approves Second Alzheimer’s Drug after Trial Shows it Can Slow Disease by 35%
Treatment Hope
“Kisunla” will be marketed by Eli Lilly, which also produces Mounjaro, a popular weight loss drug.
